Skip to main content
. 2023 Mar 3;40(2):149–154. doi: 10.4103/lungindia.lungindia_250_22

Figure 1.

Figure 1

Overview of the evaluation of Persistent post-COVID-19 cough. ACE-I: angiotensin converting enzyme inhibitor; AHR: Airway Hyperreactivity; CVA: Cough Variant Asthma; PNDS: post-nasal drip syndrome; GERD: gastro-oesophageal reflux disease; COPD: Chronic Obstructive Pulmonary Disease; ILD: Interstitial lung disease